ZA200903858B - Pharmaceutical dosage form - Google Patents

Pharmaceutical dosage form

Info

Publication number
ZA200903858B
ZA200903858B ZA2009/03858A ZA200903858A ZA200903858B ZA 200903858 B ZA200903858 B ZA 200903858B ZA 2009/03858 A ZA2009/03858 A ZA 2009/03858A ZA 200903858 A ZA200903858 A ZA 200903858A ZA 200903858 B ZA200903858 B ZA 200903858B
Authority
ZA
South Africa
Prior art keywords
dosage form
pharmaceutical dosage
pharmaceutical
dosage
Prior art date
Application number
ZA2009/03858A
Other languages
English (en)
Inventor
Priya Bawa
Viness Pillay
Yahya Choonara
Original Assignee
Univ Of Witwatesrand Johannesburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Of Witwatesrand Johannesburg filed Critical Univ Of Witwatesrand Johannesburg
Publication of ZA200903858B publication Critical patent/ZA200903858B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
ZA2009/03858A 2008-06-19 2009-06-01 Pharmaceutical dosage form ZA200903858B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA200711000 2008-06-19

Publications (1)

Publication Number Publication Date
ZA200903858B true ZA200903858B (en) 2013-10-30

Family

ID=41116789

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2009/03858A ZA200903858B (en) 2008-06-19 2009-06-01 Pharmaceutical dosage form

Country Status (5)

Country Link
US (1) US20110182987A1 (enExample)
EP (1) EP2306984A1 (enExample)
JP (1) JP2011524890A (enExample)
WO (1) WO2009153633A1 (enExample)
ZA (1) ZA200903858B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5912126B2 (ja) * 2010-11-26 2016-04-27 ユニバーシティ・オブ・ジ・ウィトウォーターズランド・ヨハネスブルクUniversity Of The Witwatersrand, Johannesburg 医薬投与形態
WO2014043084A1 (en) * 2012-09-11 2014-03-20 University Of Massachusetts Polymer-polymer composite nanoassemblies and applications thereof
FR2997605B1 (fr) * 2012-11-08 2015-12-11 Rhodia Operations Suspensions aqueuses pour compositions agricoles
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015186108A1 (en) * 2014-06-05 2015-12-10 University Of The Witwatersrand, Johannesburg 2 layers tablet oral dosage form for various drug release
AU2015290098B2 (en) 2014-07-17 2018-11-01 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
GB201511284D0 (en) * 2015-06-26 2015-08-12 Univ Witwatersrand Jhb An oral pharmaceutical dosage form for the delivery of a peptide and/or protein
EP3610862A1 (en) * 2018-08-14 2020-02-19 Apillet APS Novel oral composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002339L (sv) * 1990-07-04 1992-01-05 Kabi Pharmacia Ab Terapeutisk komposition och foerfarande foer dess framstaellning
GB9710699D0 (en) * 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
JP2000256216A (ja) * 1999-03-04 2000-09-19 Meiji Milk Prod Co Ltd ゲル組成物
CN1285333C (zh) * 2000-06-07 2006-11-22 张昊 结肠定位释放的口服制剂及其制备方法
MXPA03012041A (es) * 2001-07-04 2004-03-26 Sun Pharmaceutical Ind Ltd Sistema de administracion controlada de farmacos de retencion gastrica.
WO2003101431A1 (en) * 2002-06-04 2003-12-11 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
BRPI0418359A (pt) * 2004-01-06 2007-05-08 Univ Sherbrooke método simplificado para recuperar quitosana a partir de suas soluções ácidas
JP4694145B2 (ja) * 2004-05-17 2011-06-08 株式会社 メドレックス 経口腸溶性製剤
WO2006085075A2 (en) * 2005-02-09 2006-08-17 Da Volterra Colonic delivery of active agents
CN101511346B (zh) * 2006-09-04 2012-07-04 万能药生物有限公司 可编制的漂浮递送技术
US20080268045A1 (en) * 2006-11-09 2008-10-30 Proprius Pharmaceuticals, Inc. Sustained release methotrexate formulations and methods of use thereof

Also Published As

Publication number Publication date
JP2011524890A (ja) 2011-09-08
EP2306984A1 (en) 2011-04-13
WO2009153633A1 (en) 2009-12-23
US20110182987A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
IL207128A0 (en) Pharmaceutical dosage form
ZA201005015B (en) Solid pharmaceutical dosage form
IL237391A0 (en) Pharmaceutical combination
ZA201104336B (en) Pharmaceutical compounds
GB0816372D0 (en) Pharmaceutical compounds
GB0820819D0 (en) Pharmaceutical compounds
GB0801416D0 (en) Pharmaceutical compounds
GB0703507D0 (en) Solid pharmaceutical dose
GB0816371D0 (en) Pharmaceutical compounds
ZA201104348B (en) Pharmaceutical preparation
ZA200903858B (en) Pharmaceutical dosage form
GB0812969D0 (en) Pharmaceutical compounds
SI2271618T1 (sl) Farmacevtske spojine
GB0816370D0 (en) Pharmaceutical compounds
IL219617A0 (en) Pharmaceutical solid dosage form
GB0815972D0 (en) Pharmaceutical preparation
HU0800591D0 (en) Stable pharmaceutical combination
IL208953A0 (en) Pharmaceutical combination
GB0810857D0 (en) Pharmaceutical compounds
GB0822124D0 (en) Oral dosage form
HU0800414D0 (en) Pharmaceutical combination
ZA200903855B (en) A pharmaceutical dosage form
HK1149191A (en) Pharmaceutical dosage form
GB0802576D0 (en) Dosage form
GB0704123D0 (en) Dosage form